ArticleInternational journal of oncology2014

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine.

Hong-Quan Duong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.